Holen Sie sich die Stockscreener-App
10.32
2.89%
0.29
Handel nachbörslich:
10.50
0.18
+1.74%
Schlusskurs vom Vortag:
$10.03
Offen:
$10
24-Stunden-Volumen:
280.59K
Relative Volume:
0.49
Marktkapitalisierung:
$501.43M
Einnahmen:
$251.00K
Nettoeinkommen (Verlust:
$-87.07M
KGV:
-2.9075
EPS:
-3.5494
Netto-Cashflow:
$-80.18M
1W Leistung:
+12.79%
1M Leistung:
+7.28%
6M Leistung:
+112.78%
1J Leistung:
+186.67%
1-Tages-Spanne:
$9.93
$10.68
1-Wochen-Bereich:
$9.0435
$11.30
52-Wochen-Spanne:
$2.22
$14.53
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
Firmenname
Artiva Biotherapeutics Inc
Sektor
Branche
Telefon
(858) 267-4467
Adresse
5505 MOREHOUSE DRIVE, SAN DIEGO
Compare ARTV vs VRTX, REGN, ARGX, RVMD, ALNY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
10.32 | 487.34M | 251.00K | -87.07M | -80.18M | -3.5494 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-11 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-08-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-13 | Eingeleitet | Jefferies | Buy |
| 2024-08-13 | Eingeleitet | Needham | Buy |
| 2024-08-13 | Eingeleitet | TD Cowen | Buy |
| 2024-08-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Artiva Biotherapeutics Inc Aktie (ARTV) Neueste Nachrichten
Artiva Biotherapeutics Inc (ARTV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Artiva Biotherapeutics Inc (ARTV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
Insider Stock Purchases: July 24, 2026 - Quiver Quantitative
Thursday’s insider buys and sells: Artiva, StoneX and CoreWeave By Investing.com - Investing.com South Africa
Ra capital management, director, buys $58,306 of Artiva stock - Investing.com UK
Artiva Biotherapeutics Inc (ARTV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
RA Capital Management acquires USD 2.62 million of Artiva Biotherapeutics common shares - Bitget
Form 4 Artiva Biotherapeutics Inc For: 23 July By Investing.com - Investing.com Nigeria
Form 13D/A ARTIVA BIOTHERAPEUTICS For: 23 July By Investing.com - Investing.com Nigeria
Ra capital management, director, buys $58,306 of Artiva stock By Investing.com - Investing.com Canada
Ra Capital Management buys $2.58m in Artiva Biotherapeutics stock By Investing.com - Investing.com Canada
Ra Capital Management buys $2.58m in Artiva Biotherapeutics stock - Investing.com
ARTV Options Volatility — NASDAQ:ARTV - TradingView
ARTV Options Chain — NASDAQ:ARTV - TradingView
Artiva Biotherapeutics Sets Deadline for 2026 Meeting - TipRanks
Artiva sets 2026 annual meeting for Sept. 8; stockholder notice deadline Aug. 1 - TradingView
Artiva Biotherapeutics (Nasdaq: ARTV) details 2026 meeting deadlines - Stock Titan
Major Insider Move Signals Growing Confidence in Artiva Biotherapeutics - TipRanks
New Form 4 - Moomoo
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Form 4 Artiva Biotherapeutics Inc For: 14 July By Investing.com - Investing.com Nigeria
Ra Capital Management funds buy $194k in Artiva Biotherapeutics stock By Investing.com - Investing.com South Africa
Ra Capital Management funds buy $194k in Artiva Biotherapeutics stock - Investing.com
ARTV Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue Development StageProfit Announcement - DonanımHaber
Is Artiva Biotherapeutics, Inc. (ARTV) outperforming other medical stocks this year? - MSN
Is Artiva Biotherapeutics, Inc. (ARTV) Outperforming Other Medical Stocks This Year? - Yahoo Finance
What date does Artiva Biotherapeutics, Inc.'s (ARTV) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
ARTV Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesProduct Revenue Analysis - dars.gov.et
Artiva Biotherapeutics Q1 2026 Earnings: Wider-than-Expected Loss Highlights Pipeline Burn RatePost-Earnings Drift - dars.gov.et
Artiva Biotherapeutics (ARTV) Slips Near Key Support Level; Traders Eye $9.13 FloorImbalance Zone - dars.gov.et
Artiva Biotherapeutics at H.C. Wainwright: allogeneic cell therapy push By Investing.com - Investing.com Canada
Artiva Biotherapeutics (ARTV) Gains Ground With Support Holding at $9.21SuperTrend Flip - dars.gov.et
Major Stake Boost Signals Growing Confidence in Artiva Biotherapeutics - TipRanks
Ra capital funds buy $292k Artiva Biotherapeutics stock in late June - Investing.com South Africa
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 2000 Index - marketscreener.com
Form 4 Artiva Biotherapeutics Inc For: 29 June By Investing.com - Investing.com South Africa
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 2500 Growth Benchmark - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 2000 Value Benchmark - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM:ARTV) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 2000 Growth Benchmark - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 3000E Growth Benchmark - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM:ARTV) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Price to sales forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Price to book forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Enterprise value to revenue forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 3000 Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Price to earnings forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Artiva Biotherapeutics, Inc. advances AlloNK therapy toward Phase 3 in autoimmune disease - Traders Union
Artiva Biotherapeutics Inc (ARTV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Finanzdaten der Artiva Biotherapeutics Inc-Aktie (ARTV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):